Evaluating outcomes of endoscopic submucosal dissection for gastrointestinal lesions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to assess the procedural and clinical outcomes of patients undergoing endoscopic submucosal dissection (ESD) for gastrointestinal lesions, particularly in the esophagus and colon. Patients will receive standard medical care without any experimental interventions. ESD is a newer technique that allows for the complete removal of lesions, potentially leading to better outcomes compared to traditional methods like endoscopic mucosal resection (EMR). The study will analyze the effectiveness of ESD in a population that may differ from those in previous studies conducted primarily in Japan.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 years or older
* Scheduled to undergo ESD

Exclusion Criteria:

* Any contraindication to performing endoscopy
* Participation in another research protocol that could interfere or influence the outcomes measures of the present study.

Where it's running

• AdventHealth Orlando
  Orlando, Florida, United States Recruiting

Study contacts

• Principal investigator: Dennis Yang, MD — AdventHealth Orlando
• Study coordinator: Dennis Yang, MD
• Email: Dennis.Yang.MD@adventhealth.com
• Phone: 407-303-2570

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictors of symptom improvement after laparoscopic fundoplication

  This study tests what preoperative factors help predict which GERD patients will feel better after laparoscopic fundoplication.

  Recruiting Minia University · Minya, Minya Governorate · NCT07809620

• Potassium-Competitive Acid Blockers in Barrett’s Esophagus on PPI Therapy

  This study tests whether vonoprazan, a potassium-competitive acid blocker, can better reduce acid reflux in adults with nondysplastic Barrett’s esophagus who are already taking a daily PPI.

  Recruiting Phase 4 University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07788742

• EUS-Guided Ablation for Pancreatic and GI Lesions Registry

  This registry collects real-world data on adults undergoing EUS-guided RFA or MWA to treat pancreatic or other GI lesions during routine care to see how these treatments affect lesion size, survival, and symptoms.

  Recruiting West Virginia University · Morgantown, West Virginia · NCT07625189

• How radiofrequency ablation affects esophagus stretchiness and mucosal impedance

  This study will test whether radiofrequency ablation changes how stretchy the esophagus is and the mucosal impedance in adults treated for dysplastic Barrett's esophagus.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07126535

• Detecting Barrett's Esophagus with a Non-Endoscopic Device

  This study is testing a new capsule device that collects cells from the esophagus to see if it can effectively detect Barrett's Esophagus in people at high risk, without needing an endoscopy.

  Recruiting Cyted Health Inc · Cordova, Tennessee · NCT06803927

• Stopping routine endoscopic surveillance for low-risk Barrett's esophagus (BLISS Project)

  This project will try stopping routine endoscopies in people with low-risk, non-dysplastic Barrett's esophagus to see if it remains safe.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06803147

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.